|
|
 Previous Article | Table of Contents | Next Article 
Two New EPO Receptor Mutations: Truncated EPO Receptors Are Most Frequently Associated With Primary Familial and Congenital Polycythemias
Robert Kralovics,
Karel Indrak,
Tomas Stopka,
Brian W. Berman,
Jaroslav F. Prchal, and
Josef T. Prchal
From the Division of Hematology/Oncology, University of Alabama, Birmingham, AL; Palacky University, Olomouc, Czech Republic; and Rainbow Babies and Children Hospital, and Case Western University, Cleveland, OH.
Primary polycythemias are caused by an acquired or inborn mutation affecting hematopoietic/erythroid progenitors that results in an abnormal response to hematopoietic cytokines. Primary familial and congenital polycythemia (PFCP; also known as familial erythrocytosis) is characterized by elevated red blood cell mass, low serum erythropoietin (EPO) level, normal oxygen affinity of hemoglobin, and typically autosomal dominant inheritance. In this study we screened for mutations in the cytoplasmic domain of the EPO receptor (EPOR; exons 7 and 8 of the EPOR gene) in 27 unrelated subjects with primary or unidentified polycythemia. Two new EPOR mutations were found, which lead to truncation of the EPOR similarly to previously described mutations in PFCP subjects. The first is a 7-bp deletion (del59855991) found in a Caucasian family from Ohio. The second mutation (5967insT) was found in a Caucasian family from the Czech Republic. In both cases the EPO dose responses of the erythroid progenitors of the affected subjects were examined to confirm the diagnosis of PFCP. In one of these families, the in vitro behavior of erythroid progenitors in serum-containing cultures without the addition of EPO mimicked the behavior of polycythemia vera progenitors; however, we show that antibodies against either EPO or the EPOR distinguish the in vitro growth abnormality of polycythemia vera erythroid progenitors from that seen in this particular PFCP family. We conclude that PFCP is a disorder that appears to be associated in some families with EPOR mutations. So far, most of the described EPOR mutations (6 out of 8) associated with PFCP result in an absence of the C-terminal negative regulatory domain of the receptor.
Blood, Vol. 90 No. 5 (September 1), 1997:
pp. 2057-2061
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
L. Teofili, R. Foa, F. Giona, and L. M. Larocca
Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients?
Haematologica,
February 1, 2008;
93(2):
169 - 172.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Percy, L. M. Scott, W. N. Erber, C. N. Harrison, J. T. Reilly, F. G.C. Jones, A. R. Green, and M. F. McMullin
The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels
Haematologica,
December 1, 2007;
92(12):
1607 - 1614.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Teofili, F. Giona, M. Martini, T. Cenci, F. Guidi, L. Torti, G. Palumbo, A. Amendola, G. Leone, R. Foa, et al.
The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia
Blood,
November 1, 2007;
110(9):
3384 - 3386.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Rives, H. L. Pahl, L. Florensa, B. Bellosillo, A. Neusuess, J. Estella, K.-M. Debatin, E. Kohne, K. Schwarz, and H. Cario
Molecular genetic analyses in familial and sporadic congenital primary erythrocytosis
Haematologica,
May 1, 2007;
92(5):
674 - 677.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tefferi and A. Pardanani
Evaluation of 'Increased' Hemoglobin in the JAK2 Mutations Era: A Diagnostic Algorithm Based on Genetic Tests
Mayo Clin. Proc.,
May 1, 2007;
82(5):
599 - 604.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Teofili, F. Giona, M. Martini, T. Cenci, F. Guidi, L. Torti, G. Palumbo, A. Amendola, R. Foa, and L. M. Larocca
Markers of Myeloproliferative Diseases in Childhood Polycythemia Vera and Essential Thrombocythemia
J. Clin. Oncol.,
March 20, 2007;
25(9):
1048 - 1053.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Skoda
The Genetic Basis of Myeloproliferative Disorders
Hematology,
January 1, 2007;
2007(1):
1 - 10.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Steensma
JAK2 V617F in Myeloid Disorders: Molecular Diagnostic Techniques and Their Clinical Utility: A Paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology
J. Mol. Diagn.,
September 1, 2006;
8(4):
397 - 411.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. L. Levine and G. Wernig
Role of JAK-STAT Signaling in the Pathogenesis of Myeloproliferative Disorders
Hematology,
January 1, 2006;
2006(1):
233 - 239.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Li, M. P. Menon, V. G. Karur, S. Hegde, and D. M. Wojchowski
Attenuated signaling by a phosphotyrosine-null Epo receptor form in primary erythroid progenitor cells
Blood,
November 1, 2003;
102(9):
3147 - 3153.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tefferi
Polycythemia Vera: A Comprehensive Review and Clinical Recommendations
Mayo Clin. Proc.,
February 1, 2003;
78(2):
174 - 194.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. O. Arcasoy, A. F. Karayal, H. M. Segal, J. G. Sinning, and B. G. Forget
A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis
Blood,
April 15, 2002;
99(8):
3066 - 3069.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Mason, B. K. Beattie, Q. Liu, D. J. Dumont, and D. L. Barber
The SH2 Inositol 5-Phosphatase Ship1 Is Recruited in an SH2-dependent Manner to the Erythropoietin Receptor
J. Biol. Chem.,
February 11, 2000;
275(6):
4398 - 4406.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Watowich, X. Xie, U. Klingmuller, J. Kere, M. Lindlof, S. Berglund, and A. de la Chapelle
Erythropoietin Receptor Mutations Associated With Familial Erythrocytosis Cause Hypersensitivity to Erythropoietin in the Heterozygous State
Blood,
October 1, 1999;
94(7):
2530 - 2532.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Geissler, L. Ohler, M. Fodinger, E. Kabrna, M. Kollars, S. Skoupy, and K. Lechner
Interleukin-10 Inhibits Erythropoietin-Independent Growth of Erythroid Bursts in Patients With Polycythemia Vera
Blood,
September 15, 1998;
92(6):
1967 - 1972.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Stopka, J.H. Zivny, P. Stopkova, J.F. Prchal, and J.T. Prchal
Human Hematopoietic Progenitors Express Erythropoietin
Blood,
May 15, 1998;
91(10):
3766 - 3772.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
